Mimedx (MDXG) Retained Earnings (2010 - 2026)
Mimedx recorded quarterly Retained Earnings of -$53.5 million in Q1 2026, down 25.44% quarter-over-quarter from -$42.7 million in Q4 2025, and up 36.44% year-over-year from -$39.2 million in Q1 2025.
Mimedx's Retained Earnings history runs 17 years deep, the most recent figure standing at -$53.5 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 36.44% year-over-year to -$53.5 million; the TTM figure through Mar 2026 stood at -$53.5 million (up 36.44% YoY), while the FY2025 annual figure was -$42.7 million, up 53.23% from the prior year.
- Retained Earnings came in at -$53.5 million for Q1 2026 at Mimedx, down from -$42.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$42.7 million in Q4 2025 to a low of -$196.9 million in Q1 2023.
- A 5-year average of -$128.6 million and a median of -$124.4 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings declined 18.67% in 2022 and soared 53.23% in 2025, its largest moves.
- Mimedx's Retained Earnings stood at -$191.9 million in 2022, then soared by 30.34% to -$133.7 million in 2023, then jumped by 31.73% to -$91.3 million in 2024, then jumped by 53.23% to -$42.7 million in 2025, then retreated by 25.44% to -$53.5 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$53.5 million, -$42.7 million, and -$57.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -53.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.54 Mn |
| Dec 31, 2025 | -42.68 Mn |
| Sep 30, 2025 | -57.87 Mn |
| Jun 30, 2025 | -74.62 Mn |
| Mar 31, 2025 | -84.24 Mn |
| Dec 31, 2024 | -91.26 Mn |
| Sep 30, 2024 | -98.70 Mn |
| Jun 30, 2024 | -106.79 Mn |
| Mar 31, 2024 | -124.42 Mn |
| Dec 31, 2023 | -133.68 Mn |
| Sep 30, 2023 | -187.16 Mn |
| Jun 30, 2023 | -195.69 Mn |
| Mar 31, 2023 | -196.89 Mn |
| Dec 31, 2022 | -191.91 Mn |
| Sep 30, 2022 | -191.49 Mn |
| Jun 30, 2022 | -183.07 Mn |
| Mar 31, 2022 | -172.20 Mn |
| Dec 31, 2021 | -161.71 Mn |
| Sep 30, 2021 | -163.92 Mn |
| Jun 30, 2021 | -161.59 Mn |
| Mar 31, 2021 | -159.81 Mn |
| Dec 31, 2020 | -151.42 Mn |
| Sep 30, 2020 | -134.84 Mn |
| Jun 30, 2020 | -115.43 Mn |
| Mar 31, 2020 | -106.96 Mn |
| Dec 31, 2019 | -102.14 Mn |
| Sep 30, 2019 | -94.66 Mn |
| Jun 30, 2019 | -107.04 Mn |
| Mar 31, 2019 | -89.83 Mn |
| Dec 31, 2018 | -76.56 Mn |
| Dec 31, 2017 | -46.58 Mn |
| Sep 30, 2017 | 3.70 Mn |
| Jun 30, 2017 | -13.76 Mn |
| Mar 31, 2017 | -21.83 Mn |
| Dec 31, 2016 | -111.31 Mn |
| Sep 30, 2016 | -31.64 Mn |
| Jun 30, 2016 | -34.96 Mn |
| Mar 31, 2016 | -36.93 Mn |
| Dec 31, 2015 | -38.13 Mn |
| Sep 30, 2015 | -51.51 Mn |
| Jun 30, 2015 | -58.06 Mn |
| Mar 31, 2015 | -63.49 Mn |
| Dec 31, 2014 | -67.58 Mn |
| Sep 30, 2014 | -71.41 Mn |
| Jun 30, 2014 | -75.11 Mn |
| Mar 31, 2014 | -74.72 Mn |
| Dec 31, 2013 | -73.80 Mn |
| Sep 30, 2013 | -72.37 Mn |
| Jun 30, 2013 | -72.06 Mn |
| Mar 31, 2013 | -71.30 Mn |
| Dec 31, 2012 | -69.68 Mn |
| Sep 30, 2012 | -68.08 Mn |
| Jun 30, 2012 | -63.86 Mn |
| Mar 31, 2012 | -63.11 Mn |
| Dec 31, 2011 | -62.02 Mn |
| Sep 30, 2011 | -59.44 Mn |
| Jun 30, 2011 | -57.68 Mn |
| Dec 31, 2010 | -51.83 Mn |